ClinicalTrials.gg
Not yet recruitingNCT07868016Updated Oct 9, 2026

Clinical Evaluation of Different Bulk-Fill Restorative Materials in Primary Molars

An interventional study of Stela Capsule Bulk Fill Flowable Self-Cure Restorative and Filtek One Bulk Fill Restorative in Decayed Primary Molars, Decayed Tooth and Dentin Caries, sponsored by Burak Carıkcıoglu. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 4 Years to 9 Years. Per ClinicalTrials.gov, last updated 2026-10-09.

Sponsored by Burak Carıkcıoglu · Not applicable, Interventional, and Treatment

Updated Oct 9, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
4 Years to 9 Years
Sex
All
01

Study summary

The goal of this clinical trial is to compare the clinical performance of chemically-cured and light-cured bulk-fill composite materials used for Class II restorations in children aged 4 to 9 years with primary second molars. The main questions it aims to answer are:

What are the clinical success rates of the restorations at 12 months based on modified FDI criteria?

How do the two materials compare regarding application times, clinician ease of use, and patient satisfaction?

Researchers will compare the chemically-cured bulk-fill composite (Stela Capsule) to the light-cured bulk-fill composite (Filtek One) using a split-mouth design to see which material provides better long-term clinical performance and survival rates.

Participants will:

Receive two different bulk-fill composite restorations in matched primary second molars within the same dental arch

Visit the clinic for routine checkups and evaluations at 1 week, 3 months, 6 months, 12 months, 24 months, and 36 months

Read the detailed description

This study is designed as a prospective, single-center, double-blind, randomized controlled clinical trial with a split-mouth design. A total of 70 cooperative pediatric patients aged 4 to 9 years having bilateral primary second molars with Class II dentin caries will be enrolled. Randomization will be performed at the patient level using a permuted block randomization method with sealed envelopes to assign treatments to contralateral homologous tooth pairs. Two restorative materials will be evaluated: a chemically-cured bulk-fill flowable composite (Stela Capsule, SDI Limited) applied with Stela Primer, and a light-cured high-viscosity bulk-fill composite (Filtek One Bulk Fill Restorative, 3M Solventum) applied with Scotchbond Universal Adhesive. All restorations will be placed by a single operator following strict isolation and manufacturer instructions. Clinical evaluations will be conducted by two independent, calibrated, and blinded observers at 1 week, 3 months, 6 months, 12 months, 24 months, and 36 months using modified FDI criteria. Secondary parameters, including restoration application time, clinician ease of use (evaluated via Visual Analog Scale), patient satisfaction (measured using the Smiles Scale at 7 days), and oral hygiene indexes (Silness-Loe plaque index and gingival index), will also be recorded. Statistical analyses will include McNemar's test, Kaplan-Meier survival analysis, Generalized Estimating Equations (GEE), and mixed-effects logistic regression models.

02

Conditions studied

  • Decayed Primary Molars
  • Decayed Tooth
  • Dentin Caries

Browse trials for

Keywords

  • dental caries
  • pediatric dentistry
  • primary teeth
  • deciduous teeth
  • primary molars
  • Class II Restorations
  • Bulk-Fill Composite
  • Resin Composite
  • Dental Restoration
  • Chemically-Cured Composite
  • Light-Cured Composite
03

In context

Dental Caries

1,137 studies on the registry are indexed under Dental Caries; 201 are open to participants now.

This study's planned enrollment of 70 is above the median of 60 across 936 interventional studies indexed under Dental Caries.

Browse Dental Caries studies →

Lead sponsor

This is the only study on the registry with Burak Carıkcıoglu as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 9 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Cooperative pediatric patients aged between 4 and 9 years.
  • Presence of bilateral primary second molars with Class II dentin caries requiring restoration.
  • Teeth with positive response to vitality tests (where applicable) and no clinical signs or symptoms of irreversible pulpitis, periapical pathology, or spontaneous pain.
  • Teeth restorable with direct restorative techniques.
  • Parents or legal guardians providing signed informed consent.

Exclusion criteria

Exclusion Criteria:

  • Patients with systemic diseases, bleeding disorders, or physical/mental disabilities that prevent cooperation during dental treatment.
  • Teeth with excessive loss of tooth structure that cannot be restored with a direct restoration or requiring crown coverage.
  • Teeth with clinical or radiographic signs of pulp exposure, pulp involvement, internal/external resorption, or periapical/furcation involvement.
  • Teeth with poor oral hygiene or high caries risk where isolation is compromised.
  • Known allergy or hypersensitivity to the components of the tested materials (e.g., resin composites, primers, adhesives).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Test Group - Stela Capsule

    Direct restorative application of a chemically-cured flowable bulk-fill composite material (Stela Capsule) following the application of Stela Primer to the cavity surfaces in primary second molar Class II cavities, set without a light source.

    Device: Stela Capsule Bulk Fill Flowable Self-Cure Restorative

  • Active comparator
    Control Group - Filtek One

    Direct restorative application of a light-cured high-viscosity bulk-fill composite material (Filtek One Bulk Fill Restorative) following the application of Scotchbond Universal Adhesive, polymerized with an LED light source ($1200\~mW/cm\^{2}$) for 20 seconds.

    Device: Filtek One Bulk Fill Restorative

Interventions

  • DeviceStela Capsule Bulk Fill Flowable Self-Cure Restorative

    Direct restorative application of a chemically-cured flowable bulk-fill composite material following the application of Stela Primer to cavity surfaces in primary second molar Class II cavities

  • DeviceFiltek One Bulk Fill Restorative

    Direct restorative application of a light-cured high-viscosity bulk-fill composite material following the application of Scotchbond Universal Adhesive, polymerized with an LED light source for 20 seconds.

06

What researchers measure

Primary outcomes

  1. Clinical Success Rate Based on Modified FDI Criteria

    The clinical performance of the restorations will be evaluated using the modified World Dental Federation (FDI) criteria, which assess aesthetic, functional, and biological properties on a scale of 1 to 5. Higher scores indicate poorer clinical performance. Each restoration will be classified as either clinically acceptable (FDI scores 1-3) or clinically unacceptable (FDI scores 4-5). The overall clinical success rate will be calculated as the percentage of clinically acceptable restorations.

    Time frame: At 12 months post-operative

Secondary outcomes

  1. Long-Term Restoration Survival Rate a

    Assessment of overall restoration survival and retention rates over a 36-month period

    Time frame: At 1 week, 3 months, 6 months, 12 months, 24 months, and 36 months

  2. Restoration Application Time

    Recording the total placement time in seconds during the restorative procedure.

    Time frame: Day 1 (during the restorative procedure)

  3. Clinician Ease of Use

    Evaluating the clinician's ease of use using a Visual Analog Scale (VAS) (VAS, range 0 to 100 mm, where higher scores indicate greater ease of use).

    Time frame: Day 1 (during the restorative procedure)

  4. Patient Satisfaction

    Evaluation of the child patient's satisfaction regarding the restoration procedure measured using the Smiles Scale. (range 1 to 5, where higher scores indicate better patient satisfaction)

    Time frame: At 7 days post-operative

  5. Silness-Lõe Plaque Index Score

    Assessment of oral hygiene levels using the Silness-Lõe plaque index. (range 0 to 3, where higher scores indicate poorer oral hygiene)

    Time frame: At baseline, 6 months, 12 months, 24 months, and 36 months

  6. Gingival Index Score

    Assessment of gingival health status using the gingival index. (range 0 to 3, where higher scores indicate severe inflammation and poorer gingival health)

    Time frame: At baseline, 6 months, 12 months, 24 months, and 36 months

07

Study locations

1 site
  • Çanakkale Onsekiz Mart University
    Çanakkale, Merkez, Turkey (Türkiye)
    • Burak Çarıkçıoğlu · Contact · carikcioglub@gmail.com · +905054956091
    • Burak Çarıkçıoğlu · Principal investigator
    • Sıla Erdal · Sub investigator
08

References and documents

Publications

  • Loguercio AD, Carpio-Salvatierra B, Naupari-Villasante R, Armas-Vega A, Cavagnaro S, Leon A, Aliaga-Galvez R, Soares CJ, Gutierrez MF. Clinical evaluation of a new chemically-cured bulk-fill composite in posterior restorations: 18-Month multicenter double-blind randomized clinical trial. J Dent. 2025 Nov;162:106031. doi: 10.1016/j.jdent.2025.106031. Epub 2025 Aug 14. PubMed 40818514 ↗
  • Loguercio AD, Carpio-Salvatierra B, Naupari-Villasante R, Wendlinger M, Armas-Vega A, Cavagnaro S, Leon A, Aliaga-Galvez R, Gutierrez MF. Clinical evaluation of a new chemically-cured bulk-fill composite in posterior restorations: 6-month multicenter double-blind randomized clinical trial. J Dent. 2024 Oct;149:105246. doi: 10.1016/j.jdent.2024.105246. Epub 2024 Jul 25. PubMed 39025426 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Apr 2027, 6 months later.

Of 458 non-industry interventional studies with no phase under Dental Caries, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 31. This study's planned 6 months is below that.

Counting every sponsor, half of 486 studies reached it within 15 months; a quarter within 7 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 2, 2026
First posted
Oct 9, 2026
StartEst.
Oct 30, 2026
Primary completionEst.
Apr 30, 2027
CompletionEst.
Apr 30, 2027
Last update
Oct 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 9, 2026
Show all 1 update
  1. Oct 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07868016
Lead sponsor
Burak Carıkcıoglu
Collaborators
Çanakkale Onsekiz Mart University
Responsible party
Burak Carıkcıoglu (Associate Professor, Department of Pedodontics, Çanakkale Onsekiz Mart University) — Sponsor-investigator
First posted
Oct 9, 2026
Start date
Oct 30, 2026 (estimated)
Primary completion
Apr 30, 2027 (estimated)
Completion
Apr 30, 2027 (estimated)
Last update
Oct 9, 2026

Study contacts

Burak Çarıkçıoğlu
Contact
carikcioglub@gmail.com
+905054956091
Sıla Erdal
Contact
silaerdal13@gmail.com
+905455840010
Burak Çarıkçıoğlu
principal investigator · Çanakkale Onsekiz Mart University
Sıla Erdal
principal investigator · Çanakkale Onsekiz Mart University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion